The Splenic Microenvironment Is a Novel Site of Relapse Following ABT-199 Treatment

被引：0
|
作者：
Di Grande, Alessandra [1 ]
Piers, Sofie [2 ]
Van Vlierberghe, Pieter [2 ]
Chonghaile, Triona Ni [1 ]
机构：
[1] Royal Coll Surgeons Ireland, Physiol & Med Phys, Dublin, Ireland
[2] Univ Ghent, Dept Biomol Med, Ghent, Belgium
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-127970
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3800
引用
收藏
页数：2
相关论文
共 43 条
  • [31] EMERGENCY TREATMENT OF SPLENIC INJURY IN A NOVEL MOBILE MINIMALLY INVASIVE INTERVENTIONAL SHELTER FOLLOWING DISASTER: A FEASIBILITY STUDY
    Yao, T.
    Rong, J.
    Liang, M.
    Sun, J.
    Xuan, F.
    Zhao, L.
    Wang, X.
    Li, F.
    Wang, G.
    Han, Y.
    HEART, 2015, 101 : A37 - A37
  • [32] Emergency treatment of splenic injury in a novel mobile minimally invasive interventional shelter following disaster: a feasibility study
    Yao, Tianming
    Rong, Jingjing
    Liang, Ming
    Sun, Jingyang
    Xuan, Fengqi
    Zhao, Lijun
    Wang, Xiaozeng
    Li, Fei
    Wang, Geng
    Han, Yaling
    SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE, 2014, 22
  • [33] Emergency treatment of splenic injury in a novel mobile minimally invasive interventional shelter following disaster: a feasibility study
    Tianming Yao
    Jingjing Rong
    Ming Liang
    Jingyang Sun
    Fengqi Xuan
    Lijun Zhao
    Xiaozeng Wang
    Fei Li
    Geng Wang
    Yaling Han
    Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine, 22
  • [34] Sequential treatment with bendamustine, followed by obinutuzumab (GA101) and venetoclax (ABT-199) in patients with chronic lymphocytic leukemia (CLL): results of the CLL2-BAG phase-II-trial of the German CLL study group (GCLLSG)
    Cramer, Paula
    von Tresckow, Julia
    Bahlo, Jasmin
    Robrecht, Sandra
    Al-Sawaf, Othman
    Langerbeins, Petra
    Engelke, Anja
    Fink, Anna-Maria
    Fischer, Kirsten
    Seiler, Till
    von Weikersthal, Ludwig Fischer
    Hebart, Holger
    Kreuzer, Karl-Anton
    Rittgen, Matthias
    Kneba, Michael
    Wendtner, Clemens
    Stilgenbauer, Stephan
    Eichhorst, Barbara
    Hallek, Michael
    LEUKEMIA & LYMPHOMA, 2017, 58 : 149 - 150
  • [35] Anti-Leukemia Activity of the Selective BCL-2 Inhibitor ABT-199 in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia Is Characterized By MCL-1/BCL-2 Expression Serving As Biomarker for Treatment Response
    Seyfried, Felix
    Demir, Salih
    Horl, Rebecca
    Kohrer, Stefan
    Scheffold, Annika
    Stilgenbauer, Stephan
    Debatin, Klaus-Michael
    Meyer, Luder Hinrich
    BLOOD, 2016, 128 (22)
  • [36] Novel markers to predict virological and clinical relapse onset following antiviral treatment discontinuation in chronic hepatitis B patients
    Tuefferd, Marianne
    Crabbe, Marjolein
    Hu, Tsung-Hui
    Chen, Chi-Yi
    Chien, Rong-Nan
    Kuo-Liang, Wei
    Peng, Cheng-Yuan
    Chuang, Wan-Long
    Su, Wei-Wen
    Liang Kung-Hao
    Shen, Anna
    Lin Yu-Shuang
    Di Cara, Alessandro
    Bollekens, Jacques
    Yeh, Chau-Ting
    Spittaels, Kurt
    Aerssens, Jeroen
    JOURNAL OF HEPATOLOGY, 2020, 73 : S139 - S139
  • [37] Novel agents targeting leukemia cells and immune microenvironment for prevention and treatment of relapse of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
    Wei Shi
    Weiwei Jin
    Linghui Xia
    Yu Hu
    Acta Pharmaceutica Sinica B, 2020, 10 (11) : 2125 - 2139
  • [38] Novel agents targeting leukemia cells and immune microenvironment for prevention and treatment of relapse of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
    Shi, Wei
    Jin, Weiwei
    Xia, Linghui
    Hu, Yu
    ACTA PHARMACEUTICA SINICA B, 2020, 10 (11) : 2125 - 2139
  • [39] Combination of the glycoengineered Type II CD20 antibody obinutuzumab (GA101), and the novel Bcl-2 selective inhibitor, ABT-199 (GDC-0199), results in superior in vitro and in vivo anti-tumor activity in models of B-cell malignancies.
    Sampath, Deepak
    Herter, Sylvia
    Ingalla, Ellen
    Herting, Frank
    Bacac, Marina
    Nannini, Michelle
    Fairbrother, Wayne J.
    Klein, Christian
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [40] CD4 T CELLS MEDIATED UPREGULATION OF CCL4 CHEMOKINE DRIVES GLIOBLASTOMA TUMOR MICROENVIRONMENT REPROGRAMMING FOLLOWING TREATMENT WITH A NOVEL MRNA VACCINE
    Chauhan, Anjali
    Ebrahim, Ghaidaa
    Dastmalchi, Farhad
    McGrath, Kyle
    Thomas, Nagheme
    Takacs, Gregory Pal
    Harrison, Jeffrey
    Frain, Matthew
    Mendez-Gomez, Hector
    Sayour, Elias
    Subramaniam, Vignesh
    Angelini, Thomas
    Von Roemeling, Christina
    Mitchell, Duane
    Rahman, Maryam
    NEURO-ONCOLOGY, 2023, 25
12345